Latest News
Conference Coverage
Novel topical JAK inhibitor shows promise for atopic dermatitis
PARIS – Ruxolitinib may offer a desperately needed alternative to potent topical steroids.
Conference Coverage
Topical treatments remain a good option for psoriasis
LAS VEGAS – Creams and ointments still have a role, even in the age of biologics.
From the Journals
Second-melanoma risk higher with indoor tanning
Tanning-bed users also had less time before the diagnosis of their second tumor.
Conference Coverage
Treating psoriasis with biologics: Recommendations from an expert
LAS VEGAS – A patient’s comorbidities can help focus the choice of a biologic.
Conference Coverage
Development of reversible B-cell inhibitor XmAb5871 for SLE moves forward
Conference Coverage
Fear of blindness hobbles hydroxychloroquine treatment of SLE
From the Journals
AEDs strongly linked to rare serious skin reactions
The highest-risk AEDs were zonisamide, rufinamide, clorazepate, lamotrigine, carbamazepine, and phenytoin.
Latest News
Open enrollment: HealthCare.gov busier in week 2
Fewer plans have been selected, compared with last year, but the gap has closed since week 1.
Conference Coverage
Tofacitinib impresses in first trial for dermatomyositis
CHICAGO – Evidence of strong clinical efficacy noted.
